211 related articles for article (PubMed ID: 23055342)
21. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
22. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
24. Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.
Zhu J; Li Q; He JT; Liu GY
Int J Clin Exp Pathol; 2015; 8(12):15801-7. PubMed ID: 26884850
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of EI2BL promoted human non-small cell lung cancer progression by inducing cell EMT phenotype.
Li HR; Qiu BQ; Gao J; Jin C; Jiang JH; Ding JY
J Clin Pathol; 2020 Mar; 73(3):139-146. PubMed ID: 31586937
[TBL] [Abstract][Full Text] [Related]
26. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
[TBL] [Abstract][Full Text] [Related]
27. B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhu J; Chen C; Liu W
J Clin Pathol; 2018 Jul; 71(7):642-647. PubMed ID: 29483137
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.
Qiu ZX; Wang L; Han J; Liu D; Huang W; Altaf K; Qiu XS; Javed MA; Zheng J; Chen BJ; Li WM
Cancer Sci; 2012 Oct; 103(10):1774-9. PubMed ID: 22738312
[TBL] [Abstract][Full Text] [Related]
29. High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells.
Zhao Z; Xu Y; Lu J; Xue J; Liu P
Clin Transl Oncol; 2018 Apr; 20(4):491-499. PubMed ID: 28808929
[TBL] [Abstract][Full Text] [Related]
30. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
31. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer.
Liu PL; Tsai JR; Chiu CC; Hwang JJ; Chou SH; Wang CK; Wu SJ; Chen YL; Chen WC; Chen YH; Chong IW
Mol Carcinog; 2010 Oct; 49(10):874-81. PubMed ID: 20607726
[TBL] [Abstract][Full Text] [Related]
34. [Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism].
Cao L; Suo XJ; Jiang W; Zhao D; Yan XJ; Yang J; Ma ZY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):813-819. PubMed ID: 31770847
[No Abstract] [Full Text] [Related]
35. Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1.
Tertil M; Skrzypek K; Florczyk U; Weglarczyk K; Was H; Collet G; Guichard A; Gil T; Kuzdzal J; Jozkowicz A; Kieda C; Pichon C; Dulak J
PLoS One; 2014; 9(5):e97070. PubMed ID: 24819505
[TBL] [Abstract][Full Text] [Related]
36. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
37. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
38. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
40. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
